EmtA, a rRNA methyltransferase conferring high‐level evernimicin resistance
Paul A. Mann(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul M. McNicholas, Frank M. Aarestrup(Technical University of Denmark), Alexander S. Mankin(University of Illinois Chicago), Cara Mendrick, Todd A. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew S. Chau, David James Najarian, Christina A. Cramer, Elizabeth Coates, Richard V. Goering(Creighton University), R S Hare, David Loebenberg, Liqun Xiong(University of Illinois Chicago), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 52
Related Papers
ResFinder 4.0 for predictions of phenotypes from genotypes
|Journal of Antimicrobial Chemotherapy|2020|3.2k
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Abundance and diversity of the faecal resistome in slaughter pigs and broilers in nine European countries
|Nature Microbiology|2018|378